Joan Buenconsejo

1.4k total citations
15 papers, 779 citations indexed

About

Joan Buenconsejo is a scholar working on Statistics and Probability, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Joan Buenconsejo has authored 15 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Statistics and Probability, 4 papers in Epidemiology and 4 papers in Economics and Econometrics. Recurrent topics in Joan Buenconsejo's work include Statistical Methods in Clinical Trials (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Advanced Causal Inference Techniques (3 papers). Joan Buenconsejo is often cited by papers focused on Statistical Methods in Clinical Trials (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Advanced Causal Inference Techniques (3 papers). Joan Buenconsejo collaborates with scholars based in United States, Sweden and Brazil. Joan Buenconsejo's co-authors include Rodrigo Hasbun, Vincent Quagliarello, Holenarasipur R. Vikram, Dwight T. Janerich, S. T. Mayne, Lydia Barakat, S. T. Mayne, Samvel B. Gasparyan, Timothy Vollmer and Jana Lízrová Preiningerová and has published in prestigious journals such as JAMA, American Journal of Epidemiology and Journal of the American Society of Nephrology.

In The Last Decade

Joan Buenconsejo

14 papers receiving 744 citations

Peers

Countries citing papers authored by Joan Buenconsejo

Since Specialization

Citations

This map shows the geographic impact of Joan Buenconsejo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Buenconsejo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Buenconsejo more than expected).

Fields of papers citing papers by Joan Buenconsejo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Buenconsejo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Buenconsejo. The network helps show where Joan Buenconsejo may publish in the future.

Co-authorship network of co-authors of Joan Buenconsejo

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Buenconsejo. A scholar is included among the top collaborators of Joan Buenconsejo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Buenconsejo. Joan Buenconsejo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Accelerating drug development at Bristol Myers Squibb through innovation 2024 ·Drug Discovery Today ·Kalyanee Viraswami-Appanna, Joan Buenconsejo, Charlotte A. Baidoo, Ivan S. F. Chan, (unknown), (unknown), Ram C. Tiwari, Ling Yang, Venkat Sethuraman	2
2	From Meaningful Outcomes to Meaningful Change Thresholds: A Path to Progress for Establishing Digital Endpoints 2023 ·Therapeutic Innovation & Regulatory Science ·Marie Mc Carthy, Kate Burrows, Pip Griffiths, Peter McL. Black, Charmaine Demanuele, (unknown), Joan Buenconsejo, Nikunj Patel, (unknown), Joseph C. Cappelleri	7
3	Platform trials to evaluate the benefit-risk of COVID-19 therapeutics: Successes, learnings, and recommendations for future pandemics 2023 ·Contemporary Clinical Trials ·Joan Buenconsejo, Ran Liao, (unknown), Pritibha Singh, (unknown), Samiran Ghosh, Margaret Gamalo, Estelle Russek‐Cohen, Névine Zariffa	0
4	Design and Analysis of Studies Based on Hierarchical Composite Endpoints: Insights from the DARE-19 Trial 2022 ·Therapeutic Innovation & Regulatory Science ·Samvel B. Gasparyan, Joan Buenconsejo, (unknown), Jan Oscarsson, Olof Bengtsson, Russell Esterline, Gary G. Koch, Otávio Berwanger, Mikhail Kosiborod	13
5	Real-World Data as External Controls: Practical Experience from Notable Marketing Applications of New Therapies 2022 ·Therapeutic Innovation & Regulatory Science ·Rima Izem, Joan Buenconsejo, (unknown), (unknown), (unknown), Margaret Gamalo	13
6	Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trials 2021 ·Journal of Biopharmaceutical Statistics ·Samvel B. Gasparyan, (unknown), (unknown), Olof Bengtsson, Joan Buenconsejo, John R. Adler, Gary G. Koch	19
7	Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection: Results from the DARE-19 Randomized Controlled Trial 2021 ·Journal of the American Society of Nephrology ·Hiddo J.L. Heerspink, Remo Holanda de Mendonça Furtado, Otávio Berwanger, Gary G. Koch, Felipe A. Martínez, Omar Mukhtar, Subodh Verma, Samvel B. Gasparyan, Fengming Tang, Sheryl L. Windsor, Joan Buenconsejo, Russell Esterline, Jan Oscarsson, Phil Ambery, Anna Maria Langkilde, Mikhail Kosiborod	2
8	Effects of da pagliflozin on prevention of major clinical events and recovery in patients with re spiratory failure because of COVID‐ 19 : Design and rationale for the DARE‐19 study 2020 ·Diabetes Obesity and Metabolism ·Mikhail Kosiborod, Otávio Berwanger, Gary G. Koch, Felipe A. Martínez, Omar Mukhtar, Subodh Verma, Vijay Chopra, Ali Javaheri, Phil Ambery, Samvel B. Gasparyan, Joan Buenconsejo, C. David Sjöström, Anna Maria Langkilde, Jan Oscarsson, Russell Esterline	32
9	Statistical Opportunities to Accelerate Development for COVID-19 Therapeutics 2020 ·Statistics in Biopharmaceutical Research ·Fanni Natanegara, Névine Zariffa, Joan Buenconsejo, Ran Liao, (unknown), (unknown), Samiran Ghosh, (unknown), Margaret Gamalo	6
10	A Bayesian hierarchical model for the estimation of two incomplete surveillance data sets 2008 ·Statistics in Medicine ·Joan Buenconsejo, Durland Fish, James E. Childs, Theodore R. Holford	2
11	Complicated Left-Sided Native Valve Endocarditis in Adults 2003 ·JAMA ·Rodrigo Hasbun, Holenarasipur R. Vikram, Lydia Barakat, Joan Buenconsejo, Vincent Quagliarello	220
12	Impact of Valve Surgery on 6-Month Mortality in Adults With Complicated, Left-Sided Native Valve Endocarditis 2003 ·JAMA ·Holenarasipur R. Vikram, Joan Buenconsejo, Rodrigo Hasbun, Vincent Quagliarello	217
13	Disability and treatment patterns of multiple sclerosis patients in United States: a comparison of veterans and nonveterans. 2002 ·PubMed ·Timothy Vollmer, Olympia Hadjimichael, Jana Lízrová Preiningerová, Weijia Ni, Joan Buenconsejo	29
14	Previous Lung Disease and Risk of Lung Cancer among Men and Women Nonsmokers 1999 ·American Journal of Epidemiology ·S. T. Mayne, Joan Buenconsejo, Dwight T. Janerich	165
15	Familial cancer history and lung cancer risk in United States nonsmoking men and women. 1999 ·PubMed ·S. T. Mayne, Joan Buenconsejo, Dwight T. Janerich	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact